PerpEquities

Equity

Exelixis, Inc. (EXEL) perpetual futures

EXEL perpetual futures on 1 crypto exchanges – live perp price vs the stock, funding rate, open interest and where to trade EXELUSDT.

Exelixis is a US biotechnology company focused on developing and commercializing cancer therapies, including CABOMETYX and COMETRIQ.

$70.59+1.4%NASDAQ open
Open in terminal

Price chart

Interactive TradingView chart

TradingView symbol NASDAQ:EXEL

Loads TradingView's third-party widget (about 1 MB) on demand.

Auto: underlying reference priceOpen in TradingView

Trading data

Perpetual market activity

1/1 live markets
Venues
1
Live markets
1/1
24h volume
$322.2K
Open interest
$6.9K
Best liquidity
$29.4K
BingX
Tightest spread
+15.6 bps
BingX
Highest volume
$322.2K
BingX
Settlement mix
USDT · 1/1
Perp/spot vol.
0.00x
Spot volume $200.3M
OI / float
0.00%
Float $15.1B
Spot performance
1D-0.12%
5D+1.61%
1M+12.87%
6M+48.13%
YTD+51.04%
1Y+67.89%

Venue matrix

1 markets

Some venue links are sponsored. We may receive a commission, and eligible users may occasionally receive trading-fee discounts, at no additional cost to you.

Trade
BingXTradeEXEL-USDTTrading$70.59-1.1% APR
-0.00100% every 8h
+15.6 bps$29.4K$322.2K$6.9KUSDT-

Tradability

Execution quality

Entry cost and depth per venue at $1k–$100k

Thin liquidity · 1 of 1 venues absorb $10k · Typical cost: +47.4 bps

Cheapest execution: BingX · +47.4 bps

Taker execution estimate incl. approx. fees - maker fills are not guaranteed.

Best venues for this underlying

Best liquidity

EXEL

Tightest spread

EXEL

Highest volume

EXEL

Funding history

Stored venue snapshots by market

Company data

Company fundamentals

Updated 27m ago
Market cap
$18B
Updated 27m ago
Revenue
$2.5B
Trailing 12 months
Revenue growth
+10%
Next fiscal year
Profit margin
+35.5%
P/E
20.8
Peer P/E 16.1
Free cash flow
$1.2B
Trailing 12 months
More metrics
Net income
$885.1M
Trailing 12 months
P/S
7.2
Peer P/E
16.1
Similar listed perps
Revenue estimate
$2.6B
Next fiscal year
Earnings
2026-10-29
Revenue $658.7M · Updated 27m ago
Dividend
-

Fundamental detail

Annual + quarterly
Latest revenue$2.3B
Net margin+33.7%
Free cash flow$844.3M
Net debt-$309.5M
2020$987.5M
2021$1.4B
2022$1.6B
2023$1.8B
2024$2.2B
2025$2.3B
PeriodRevenueGrowthNet incomeFCF
2020$987.5M+2%$111.8M$178.6M
2021$1.4B+45%$231.1M$336.6M
2022$1.6B+12%$182.3M$224.2M
2023$1.8B+14%$207.8M$170.4M
2024$2.2B+18%$521.3M$633.8M
2025$2.3B+7%$782.6M$844.3M
PeriodGross marginOperating marginNet marginROEROA
2020+96.3%+11.1%+11.3%+5.9%+5.2%
2021+96.3%+20.0%+16.1%+10.5%+8.8%
2022+96.4%+12.5%+11.3%+7.3%+5.9%
2023+96.0%+9.3%+11.4%+9.2%+7.1%
2024+96.5%+27.9%+24.0%+23.2%+17.7%
2025+96.4%+37.6%+33.7%+36.2%+27.5%
PeriodCashDebtNet debtCurrent ratio
2020$319.2M$49.1M-$270.1M7.06
2021$647.2M$51.3M-$595.9M5.43
2022$501.2M$190.2M-$311M4.99
2023$263M$189.9M-$73.1M3.34
2024$217.4M$190.8M-$26.6M3.63
2025$482.5M$173M-$309.5M3.56
PeriodMarket capEnterprise valueP/SP/E
2020$6.2B$5.9B6.355.8
2021$5.8B$5.2B4.025.0
2022$5.2B$4.8B3.228.1
2023$7.6B$7.6B4.236.9
2024$9.9B$9.8B4.518.9
2025$11.8B$11.5B5.115.1
Q4 2024$566.8M
Q1 2025$555.4M
Q2 2025$568.3M
Q3 2025$597.8M
Q4 2025$598.7M
Q1 2026$610.8M
Q2 2026$628.7M
Q3 2026$658.7M
PeriodRevenueGrowthNet incomeFCF
Q4 2024$566.8M+18%$139.9M$226.3M
Q1 2025$555.4M+31%$159.6M$189M
Q2 2025$568.3M-11%$184.8M$45.4M
Q3 2025$597.8M+11%$193.6M$283.6M
Q4 2025$598.7M+6%$244.5M$326.4M
Q1 2026$610.8M+10%$210.5M$249.8M
Q2 2026$628.7M+11%$212.1M$298.4M
Q3 2026$658.7M+10%$218.1M$291.3M
PeriodGross marginOperating marginNet marginROEROA
Q4 2024+96.5%+28.8%+24.7%+6.2%+4.7%
Q1 2025+96.5%+33.6%+28.7%+7.5%+5.6%
Q2 2025+96.6%+37.6%+32.5%+9.1%+6.9%
Q3 2025+96.9%+39.6%+32.4%+9.0%+6.9%
Q4 2025+95.6%+39.3%+40.8%+11.3%+8.6%
Q1 2026+96.7%+41.1%+34.5%+10.9%+8.1%
Q2 2026+96.7%+39.5%+33.7%+11.5%+8.5%
Q3 20260.0%+40.8%+33.1%+11.9%+8.7%
PeriodCashDebtNet debtCurrent ratio
Q4 2024$217.4M$190.8M-$26.6M3.63
Q1 2025$183.8M$187.1M$3.4M3.50
Q2 2025$164.4M$179.8M$15.4M3.51
Q3 2025$376.3M$176.5M-$199.8M3.75
Q4 2025$482.5M$173M-$309.5M3.56
Q1 2026$226.2M$169.5M-$56.6M3.26
Q2 2026$281.4M$165.9M-$115.5M3.46
Q3 2026$304.8M$162.2M-$142.6M3.21
PeriodMarket capEnterprise valueP/SP/E
Q4 2024$9.5B$9.4B16.717.3
Q1 2025$9.6B$9.6B17.415.2
Q2 2025$12.6B$12.6B22.117.0
Q3 2025$10.8B$10.6B18.013.9
Q4 2025$11.8B$11.5B19.812.0
Q1 2026$11.3B$11.3B18.613.5
Q2 2026$14B$13.9B22.316.4
Q3 2026$14.4B$14.3B21.916.6

Refreshed 27m ago

Charts: revenue, profit, cash flow & valuation
Revenue$658.7MQ3 2026
$164.7M$329.3M$494M$658.7MQ4 2023: $479.7MQ1 2024: $425.2MQ2 2024: $637.2MQ3 2024: $539.5MQ4 2024: $566.8MQ1 2025: $555.4MQ2 2025: $568.3MQ3 2025: $597.8MQ4 2025: $598.7MQ1 2026: $610.8MQ2 2026: $628.7MQ3 2026: $658.7MQ4 2023Q3 2026
Net income$218.1MQ3 2026
$61.1M$122.3M$183.4M$244.5MQ4 2023: $85.5MQ1 2024: $37.3MQ2 2024: $226.1MQ3 2024: $118MQ4 2024: $139.9MQ1 2025: $159.6MQ2 2025: $184.8MQ3 2025: $193.6MQ4 2025: $244.5MQ1 2026: $210.5MQ2 2026: $212.1MQ3 2026: $218.1MQ4 2023Q3 2026
EBITDA$268.4MQ3 2026
$70.9M$141.8M$212.8M$283.7MQ4 2023: $109.6MQ1 2024: $68.7MQ2 2024: $283.7MQ3 2024: $195.3MQ4 2024: $171.1MQ1 2025: $213MQ2 2025: $237.8MQ3 2025: $259.8MQ4 2025: $242.9MQ1 2026: $274.6MQ2 2026: $269.7MQ3 2026: $268.4MQ4 2023Q3 2026
Free cash flow$291.3MQ3 2026
$79.7M$161.9M$244.1M$326.4MQ4 2023: -$2.6MQ1 2024: $50.6MQ2 2024: $94.7MQ3 2024: $262.1MQ4 2024: $226.3MQ1 2025: $189MQ2 2025: $45.4MQ3 2025: $283.6MQ4 2025: $326.4MQ1 2026: $249.8MQ2 2026: $298.4MQ3 2026: $291.3MQ4 2023Q3 2026
EPS$0.85Q3 2026
$0.22$0.44$0.66$0.88Q4 2023: $0.27Q1 2024: $0.12Q2 2024: $0.77Q3 2024: $0.4Q4 2024: $0.47Q1 2025: $0.55Q2 2025: $0.65Q3 2025: $0.7Q4 2025: $0.88Q1 2026: $0.79Q2 2026: $0.82Q3 2026: $0.85Q4 2023Q3 2026
Cash / Debt$304.8MQ3 2026
$120.6M$241.2M$361.9M$482.5MQ4 2023 · Cash: $263MQ4 2023 · Debt: $189.9MQ1 2024 · Cash: $259.6MQ1 2024 · Debt: $201.5MQ2 2024 · Cash: $198.5MQ2 2024 · Debt: $198MQ3 2024 · Cash: $258.3MQ3 2024 · Debt: $194.4MQ4 2024 · Cash: $217.4MQ4 2024 · Debt: $190.8MQ1 2025 · Cash: $183.8MQ1 2025 · Debt: $187.1MQ2 2025 · Cash: $164.4MQ2 2025 · Debt: $179.8MQ3 2025 · Cash: $376.3MQ3 2025 · Debt: $176.5MQ4 2025 · Cash: $482.5MQ4 2025 · Debt: $173MQ1 2026 · Cash: $226.2MQ1 2026 · Debt: $169.5MQ2 2026 · Cash: $281.4MQ2 2026 · Debt: $165.9MQ3 2026 · Cash: $304.8MQ3 2026 · Debt: $162.2MQ4 2023Q3 2026
CashDebt
Profitability0.0%Q3 2026
+24.3%+48.6%+72.9%+97.2%Q4 2023 · Gross margin: +95.5%Q1 2024 · Gross margin: +95.0%Q2 2024 · Gross margin: +97.2%Q3 2024 · Gross margin: +96.8%Q4 2024 · Gross margin: +96.5%Q1 2025 · Gross margin: +96.5%Q2 2025 · Gross margin: +96.6%Q3 2025 · Gross margin: +96.9%Q4 2025 · Gross margin: +95.6%Q1 2026 · Gross margin: +96.7%Q2 2026 · Gross margin: +96.7%Q3 2026 · Gross margin: 0.0%Q4 2023 · Operating margin: +17.1%Q1 2024 · Operating margin: +6.9%Q2 2024 · Operating margin: +43.3%Q3 2024 · Operating margin: +25.2%Q4 2024 · Operating margin: +28.8%Q1 2025 · Operating margin: +33.6%Q2 2025 · Operating margin: +37.6%Q3 2025 · Operating margin: +39.6%Q4 2025 · Operating margin: +39.3%Q1 2026 · Operating margin: +41.1%Q2 2026 · Operating margin: +39.5%Q3 2026 · Operating margin: +40.8%Q4 2023 · Net margin: +17.8%Q1 2024 · Net margin: +8.8%Q2 2024 · Net margin: +35.5%Q3 2024 · Net margin: +21.9%Q4 2024 · Net margin: +24.7%Q1 2025 · Net margin: +28.7%Q2 2025 · Net margin: +32.5%Q3 2025 · Net margin: +32.4%Q4 2025 · Net margin: +40.8%Q1 2026 · Net margin: +34.5%Q2 2026 · Net margin: +33.7%Q3 2026 · Net margin: +33.1%Q4 2023Q3 2026
Gross marginOperating marginNet margin
Revenue growth+10.2%Q3 2026
-0.5%+9.9%+20.3%+30.6%Q3 2024: +14.3%Q4 2024: +18.2%Q1 2025: +30.6%Q2 2025: -10.8%Q3 2025: +10.8%Q4 2025: +5.6%Q1 2026: +10.0%Q2 2026: +10.6%Q3 2026: +10.2%Q4 2023Q3 2026
Shares outstanding255.8MQ3 2026
78.3M156.5M234.8M313MQ4 2023: 313MQ1 2024: 305.5MQ2 2024: 294MQ3 2024: 291.5MQ4 2024: 293.5MQ1 2025: 288.2MQ2 2025: 284.4MQ3 2025: 278.5MQ4 2025: 281.9MQ1 2026: 267.3MQ2 2026: 259.7MQ3 2026: 255.8MQ4 2023Q3 2026
Valuation16.6Q3 2026
12.424.737.149.4Q4 2023 · P/E: 21.4Q1 2024 · P/E: 49.4Q2 2024 · P/E: 7.2Q3 2024 · P/E: 15.8Q4 2024 · P/E: 17.3Q1 2025 · P/E: 15.2Q2 2025 · P/E: 17.0Q3 2025 · P/E: 13.9Q4 2025 · P/E: 12.0Q1 2026 · P/E: 13.5Q2 2026 · P/E: 16.4Q3 2026 · P/E: 16.6Q4 2023 · P/S: 15.4Q1 2024 · P/S: 16.8Q2 2024 · P/S: 10.2Q3 2024 · P/S: 13.7Q4 2024 · P/S: 16.7Q1 2025 · P/S: 17.4Q2 2025 · P/S: 22.1Q3 2025 · P/S: 18.0Q4 2025 · P/S: 19.8Q1 2026 · P/S: 18.6Q2 2026 · P/S: 22.3Q3 2026 · P/S: 21.9Q4 2023Q3 2026
P/EP/S
Revenue$2.3B2025
$580M$1.2B$1.7B$2.3B2018: $853.8M2019: $967.8M2020: $987.5M2021: $1.4B2022: $1.6B2023: $1.8B2024: $2.2B2025: $2.3B20182025
Net income$782.6M2025
$195.6M$391.3M$586.9M$782.6M2018: $690.1M2019: $321M2020: $111.8M2021: $231.1M2022: $182.3M2023: $207.8M2024: $521.3M2025: $782.6M20182025
EBITDA$921.8M2025
$230.4M$460.9M$691.3M$921.8M2018: $446.6M2019: $406.5M2020: $119.2M2021: $307.8M2022: $255.2M2023: $283.2M2024: $718.8M2025: $921.8M20182025
Free cash flow$844.3M2025
$211.1M$422.2M$633.3M$844.3M2018: $382.4M2019: $514.1M2020: $178.6M2021: $336.6M2022: $224.2M2023: $170.4M2024: $633.8M2025: $844.3M20182025
EPS$2.782025
$0.7$1.39$2.09$2.782018: $2.212019: $1.022020: $0.352021: $0.722022: $0.562023: $0.652024: $1.762025: $2.7820182025
Cash / Debt$482.5M2025
$161.8M$323.6M$485.4M$647.2M2018 · Cash: $314.8M2018 · Debt: $14.9M2019 · Cash: $266.5M2019 · Debt: $50.7M2020 · Cash: $319.2M2020 · Debt: $49.1M2021 · Cash: $647.2M2021 · Debt: $51.3M2022 · Cash: $501.2M2022 · Debt: $190.2M2023 · Cash: $263M2023 · Debt: $189.9M2024 · Cash: $217.4M2024 · Debt: $190.8M2025 · Cash: $482.5M2025 · Debt: $173M20182025
CashDebt
Profitability+96.4%2025
+24.2%+48.5%+72.7%+96.9%2018 · Gross margin: +96.9%2019 · Gross margin: +96.6%2020 · Gross margin: +96.3%2021 · Gross margin: +96.3%2022 · Gross margin: +96.4%2023 · Gross margin: +96.0%2024 · Gross margin: +96.5%2025 · Gross margin: +96.4%2018 · Operating margin: +51.4%2019 · Operating margin: +38.2%2020 · Operating margin: +11.1%2021 · Operating margin: +20.0%2022 · Operating margin: +12.5%2023 · Operating margin: +9.3%2024 · Operating margin: +27.9%2025 · Operating margin: +37.6%2018 · Net margin: +80.8%2019 · Net margin: +33.2%2020 · Net margin: +11.3%2021 · Net margin: +16.1%2022 · Net margin: +11.3%2023 · Net margin: +11.4%2024 · Net margin: +24.0%2025 · Net margin: +33.7%20182025
Gross marginOperating marginNet margin
Revenue growth+7.0%2025
+11.3%+22.7%+34.0%+45.3%2019: +13.3%2020: +2.0%2021: +45.3%2022: +12.3%2023: +13.6%2024: +18.5%2025: +7.0%20182025
Shares outstanding281.9M2025
81.1M162.3M243.4M324.6M2018: 312.8M2019: 315M2020: 318M2021: 322.4M2022: 324.6M2023: 321.5M2024: 296.1M2025: 281.9M20182025
Valuation15.12025
13.927.941.855.82018 · P/E: 8.52019 · P/E: 16.62020 · P/E: 55.82021 · P/E: 25.02022 · P/E: 28.12023 · P/E: 36.92024 · P/E: 18.92025 · P/E: 15.12018 · P/S: 6.92019 · P/S: 5.52020 · P/S: 6.32021 · P/S: 4.02022 · P/S: 3.22023 · P/S: 4.22024 · P/S: 4.52025 · P/S: 5.120182025
P/EP/S

Next catalyst

Catalysts

Earnings
2026-10-29
Revenue $658.7M · Updated 27m ago

No unusual perp activity right now.

Research data

Analysts, filings and peer context

Estimates

6
DateEPS estimateRevenue estimateGrowthAnalysts
FY 20273.59$2.6B+10%9
FY 20284.17$2.9B+24%9
FY 20295.18$3.3B+42%7
FY 20306.37$3.6B+57%2
FY 20315.28$3.3B+42%3
Q2 20270.92$666.5M+6%3

Company events

6
2026-10-29Earnings · After market closeActual 0.94 / Estimate 0.89Beat
2026-08-05EarningsActual 0.91 / Estimate 0.85Beat
2026-05-05EarningsActual 0.87 / Estimate 0.77Beat
2026-02-10EarningsActual 0.94 / Estimate 0.77Beat
2025-11-04EarningsActual 0.78 / Estimate 0.69Beat
2025-07-28EarningsActual 0.75 / Estimate 0.65Beat

Peer comparison

Similar listed perps

Analyst track record

How the analysts covering EXEL have done: ratings, price-target accuracy and the measured reaction after their calls.

12 months3 years
Ratings120430
Analysts2635
Buy / hold / sell39 / 75 / 6243 / 176 / 11
Upgrades / downgrades / initiations0 / 4 / 33 / 9 / 12
Price targets hit / missed93 / 0 (100%)366 / 0 (100%)
Avg. return after a rating (TipRanks)+38.6%+86.4%
Best / worst call+86.0% / +0.2%+261.7% / +0.2%

After buy calls on this stock: median 21-day move +3.5% vs S&P 500 +0.3% (n = 252)

Most accurate on this stock

Share of an analyst's price targets on this stock that the price reached within 12 months (our measurement over the last 3 years, at least 8 targets). It describes past calls, not the odds of the current one.

  1. Silvan TuerkcanCitizens JMP100% hit rate on this stock · 26 targets measuredBuytarget $65.00Oct 19, 2026
  2. Gregory RenzaTruist Financial100% hit rate on this stock · 18 targets measuredHoldtarget $54.00Oct 7, 2026
  3. Robert BurnsH.C. Wainwright100% hit rate on this stock · 17 targets measuredBuytarget $56.00Jul 2, 2026

Latest ratings

DateAnalystCallTarget
Oct 30, 2026David LebowitzBMO CapitalHoldReiterated$60.00
Oct 29, 2026Unknown AnalystGuggenheimHoldMaintained–
Oct 29, 2026Leonid TimashevRBC CapitalHoldMaintained$58.00
Oct 30, 2026Etzer DaroutBarclaysHoldMaintained$54.00
Oct 30, 2026Etzer DaroutBarclaysHoldMaintained$54.00
Consensus over the last 12 months buy hold sell avg. target month-end close
Monthly buy, hold and sell shares of analyst ratings with the average price target and the month-end close$40.00$45.00$50.00$55.00$60.00$65.00Nov 25 · Buy 12 · Hold 10 · Sell 0Nov 25Dec 25 · Buy 11 · Hold 10 · Sell 0Jan 26 · Buy 9 · Hold 8 · Sell 1Jan 26Feb 26 · Buy 10 · Hold 9 · Sell 1Mar 26 · Buy 9 · Hold 9 · Sell 1Mar 26Apr 26 · Buy 8 · Hold 9 · Sell 1May 26 · Buy 8 · Hold 9 · Sell 1May 26Jun 26 · Buy 7 · Hold 10 · Sell 1Jul 26 · Buy 6 · Hold 12 · Sell 1Jul 26Aug 26 · Buy 5 · Hold 13 · Sell 1Sep 26 · Buy 4 · Hold 14 · Sell 1Sep 26Oct 26 · Buy 5 · Hold 13 · Sell 1Nov 25 · avg. target $45.88Dec 25 · avg. target $44.47Jan 26 · avg. target $45.64Feb 26 · avg. target $46.94Mar 26 · avg. target $46.33Apr 26 · avg. target $47.08May 26 · avg. target $47.33Jun 26 · avg. target $48.14Jul 26 · avg. target $50.93Aug 26 · avg. target $50.75Sep 26 · avg. target $51.14Oct 26 · avg. target $52.50Nov 25 · month-end close $44.17Dec 25 · month-end close $43.83Jan 26 · month-end close $41.36Feb 26 · month-end close $44.06Mar 26 · month-end close $42.89Apr 26 · month-end close $44.46May 26 · month-end close $50.48Jun 26 · month-end close $54.41Jul 26 · month-end close $53.03Aug 26 · month-end close $54.64Sep 26 · month-end close $58.41Oct 26 · month-end close $64.53

Share of analysts per call each month (latest call per analyst within 180 days). Targets and closes in USD.

TipRanks data via FMP · computed Oct 30, 2026 · 120 ratings

Frequently asked questions

Where can I trade EXEL perpetual futures?

Exelixis, Inc. (EXEL) perpetual futures trade on 1 crypto venues, including BingX. PerpEquities compares them by live price, funding rate, open interest and liquidity.

Can I trade EXEL around the clock?

Yes. Unlike the underlying stock, EXEL perpetuals trade 24/7 — including weekends and outside regular market hours.

What is the funding rate on EXEL perpetuals?

Right now the EXEL perp funding rate is -1.1% annualized (venue median), ranging from -1.1% to -1.1% across 1 venues. A positive rate means longs pay shorts. PerpEquities shows the live rate and its history for every venue.

How does the EXEL perp price compare to the Exelixis, Inc. stock?

The venue-median EXEL perp mark is $70.6 versus a reference stock price of $70.6, a basis of 0.0%. Perps follow the stock through an index price; the gap widens when funding or liquidity diverge between venues.

What is a EXEL perpetual future?

A EXEL perpetual is a derivative that tracks the price of Exelixis, Inc. with no expiry date. It lets you take long or short exposure to Exelixis, Inc. on crypto venues, around the clock.

What is EXELUSDT perpetual?

EXELUSDT is the symbol most crypto exchanges use for the Exelixis, Inc. perpetual settled in USDT (Tether). It tracks the EXEL share price through an index, trades 24/7 with leverage and never expires.

Embed this asset

EXEL perpetuals · perpequities.comEXEL perpetuals · perpequities.com
<a href="https://perpequities.com/stocks/exel-perp"><img src="https://perpequities.com/badge/exel-perp.svg" width="240" height="64" alt="EXEL perpetuals · perpequities.com" loading="lazy"></a>

Next step

Stay on top of EXEL perps

Signals with a track record

Analysts who hit 70%+ of their targets on the perps we track, congress buys over $500k, 13F positions over $5M, funding spreads that have paid for days. Every post shows the evidence. Free, no sign-up.

Join on Telegram

Weekly digest by email

The listings, funding and moves that matter for EXEL — one email every Sunday.

Watchlist and alerts

Price and funding alerts for EXEL, via push or Telegram.

Set an alert

Follow the live feed

Daily movers, new listings and funding extremes as they happen.

Follow on X